Livestock Healthcare Global Market Report 2024

The livestock healthcare market size has grown strongly in recent years. It will grow from $50.74 billion in 2023 to $54.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing livestock population, intensification of livestock farming, rising demand for animal products, globalization of the livestock industry, government initiatives for livestock health.

The livestock healthcare market size is expected to see strong growth in the next few years. It will grow to $79.39 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to evolving disease landscape, focus on antibiotic reduction, growing awareness of zoonotic diseases, adoption of precision livestock farming, sustainable livestock practices. Major trends in the forecast period include biosecurity measures for disease prevention, genetic selection for disease resistance, remote consultation and veterinary services, focus on animal welfare and stress reduction, emergence of personalized medicine for livestock.

The increasing prevalence of food-borne and zoonotic diseases is expected to propel the livestock healthcare market going forward. Foodborne refers to infectious diseases caused by the consumption of food or water contaminated by pathogenic microorganisms such as bacteria, parasites, and viruses. Zoonotic diseases are illnesses that are transmitted between animals and humans. Livestock healthcare helps to detect, prevent, and treat diseases from animals through vaccines and medications, so increasing food-borne and zoonotic diseases increases the demand for livestock healthcare products. For instance, in December 2022, according to the European Food Safety Authority, an Italy-based decentralized agency of the European Union, in Europe, there were 127,840 recorded cases of zoonotic diseases in 2021. Therefore, the increasing prevalence of food-borne and zoonotic diseases drives the livestock healthcare market.


The increasing livestock population is expected to propel the growth of the livestock healthcare market going forward. Livestock population refers to the total number of domesticated animals raised by humans for various purposes, such as food, fiber, labor, and other products. The livestock population requires livestock healthcare to maintain economic stability, ensure food security, support farmers' livelihoods, promote sustainable agricultural practices, and prevent and control the spread of diseases. For instance, in 2021, according to Eurostat, a Luxembourg-based statistical office of the European Union (EU) responsible for publishing high-quality Europe-wide statistics, the livestock population in the European Union was around 142 million pigs, 76 million bovine animals, 60 million sheep, and 11 million goats. Therefore, the increasing livestock population is driving the growth of the livestock healthcare market going forward.


Technological innovations are a key trend gaining popularity in the livestock healthcare market. Major companies operating in the livestock healthcare market are focused on developing new technological solutions to strengthen their market position. For instance, in July 2022, Merck Animal Health, a US-based biopharmaceutical company that develops and produces medicines and vaccines, launched Whisper on Arrival, a first-of-its-kind technology that transforms decision-making for cattle. It is uniquely designed with specialized sound-gathering equipment and a predictive algorithm that helps to analyze animal breathing, heartbeat, weight, and rectal temperature and offers useful information to feedlot managers and vets for decisions involving specific animals. It aids in formulating a plan of action for the management of bovine respiratory disease (BRD) and identifies the cattle that may be more susceptible to illness.

Major companies operating in the livestock healthcare market are focused on introducing advanced solutions, such as ayurvedic formulations, to gain a competitive edge in the market. Ayurvedic formulations are traditional herbal preparations and remedies used in Ayurveda, a system of medicine with historical roots based on plants, animals extract, and minerals. For instance, in September 2023, Milma, an India-based dairy company launched ethno-veterinary medicines. Ethno-veterinary medicines are medicines made from Ayurvedic formulations and are designed to treat animal diseases. Ethno-veterinary medicines are used as low-cost alternatives to allopathic veterinary drugs. This medicines lessen the burden of veterinary expenses on farmers and provide a cost-effective solution for animal healthcare. This medicines are a simple, cost-effective, farmer-friendly tool that are used as preventives and curatives.


In September 2022, Zoetis Inc., a US-based producer of medicine and vaccinations for pets and livestock, acquired Jurox Animal Health for an undisclosed amount. Through this acquisition, combined resources with Jurox are expected to increase the range of products offered and the potential for global expansion for Zoetis. Jurox Animal Health is an Australian-based developer and producer of veterinary pharmaceutical solutions for livestock producers, veterinarians, and pet owners.

Major companies operating in the livestock healthcare market report are The Archer-Daniels-Midland Company, Merck & Co Inc., Boehringer Ingelheim International GmbH, Bayer Healthcare AG, Zoetis Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Alltech Inc., Virbac SA, Ceva Santé Animale, Phibro Animal Health Corporation, Avivagen Inc., Neogen Corporation, Dechra Pharmaceuticals PLC, Huvepharma AD, Vetoquinol SA, Laboratorios Hipra S.A., Anpario PLC, Kemin Industries Inc., Norbrook Laboratories Ltd., Alivira Animal Health Limited, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Hester Biosciences Limited, BioChek BV, Vets Plus Inc., Phytobiotics Futterzusatzstoffe GmbH, Delacon Biotechnik GmbH, Bimeda Holdings PLC, Inovet (V.M.D. nv/sa)

North America was the largest region in the livestock healthcare market in 2023. The regions covered in the livestock healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the livestock healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of livestock healthcare are vaccines, pharmaceuticals, feed additives, diagnostics, and other types. Feed additives are single ingredients or substances used in animal nutrition to improve the quality of feed and animal-derived foods. It contributes to the health and performance of the animals. These are applied to various livestock animals such as poultry, swine, cattle, sheep and goats, horses, and others and are used by various end users such as reference laboratories, point-of-care testing or in-house testing, veterinary hospitals and clinics, and others.

The livestock healthcare market research report is one of a series of new reports that provides livestock healthcare market statistics, including livestock healthcare industry global market size, regional shares, competitors with a livestock healthcare market share, detailed livestock healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the livestock healthcare industry. This livestock healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The livestock healthcare market consists of sales of livestock medications such as biologics and tick medications as well as tools for livestock disease diagnosis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.